Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)

Trial Profile

Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 May 2017

At a glance

  • Drugs Patiromer (Primary)
  • Indications Hyperkalaemia
  • Focus Therapeutic Use
  • Acronyms REDUCE
  • Most Recent Events

    • 05 May 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2016.
    • 18 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top